Trusted Resources: Education
Scientific literature and patient education texts
Fetal Therapies and Trials for Lysosomal Storage Diseases: A Survey of Attitudes of Parents and Patients
source: Orphanet journal of rare diseases
year: 2022
authors: Schwab ME,Brown JEH,Lianoglou B,Jin C,Conroy PC,Gallagher RC,Harmatz P,MacKenzie TC
summary/abstract:Lysosomal storage diseases (LSDs) are inherited metabolic disorders that may lead to severe multi-organ disease. Current ERTs are limited by anti-drug antibodies, the blood-brain barrier, and early disease onset and progression before ERT is started. We have opened a phase I clinical trial of enzyme replacement therapy (ERT) for fetuses with LSDs (NCT04532047). We evaluated the attitudes of parents and patients with LSDs towards fetal clinical trials and therapies.
organization: Fetal Treatment Center, University of California, San Francisco, CA, USA.DOI: 10.1186/s13023-022-02178-z
read more
BookmarkRelated Content
-
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler SyndromeAllogeneic hematopoietic stem-cell trans...
-
A 22 Year Old Rotherham Man, no Longer Walk Up His StairsA Yorkshire community has launched a fun...
-
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzy...Cardiovascular involvement is among the ...
-
Europe Grants Orphan Drug Status to JR-441, ERT for Sanfilippo AThe European Commission has granted an o...
-
Mucopolysacharidosis Type I Presenting as Bipolar Affective Disorder: A Case ReportMucopolysacharidosis type I is a multisy...
-
Mucopolysaccharide Storage Disease Type I: Hurler, Hurler-Scheie, and Scheie Syndromeshttps://www.youtube.com/watch?v=en9M2P8S...
-
University of Minnesota – Mucopolysaccharidosis (MPS) CenterOur MPS Center is internationally recogn...
Powered by
